Deler fremragende | 656,270,644 shares |
Insideraktier | 81.679.507 shares |
Insider ejerskab | 12,45 % |
Total Insiders | 24 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
CannaPharmaRX, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Marc R Branson | 0 | ||
Gary Michael Cohen
10% Owner -
|
19.421.120 | 19.421.120 | |
Gerald Eugene Jr Crocker
10% Owner -
|
60.000 | 60.000 | |
CannaPharmaRX, Inc. - | 0 | 0 | |
John Hamilton Cassels Chief Financial Officer - [O] | 8.000 | 8.000 | |
Dominic Colvin Chief Executive Officer, Director - [D] [O] | 7.988.963 | 7.988.963 | |
David J Cutler Director - [D] | 0 | 0 | |
Wendy F Dicicco | 50.000 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Alexander R Giaquinto | 50.000 | ||
Redgie T Green Director - [D] | 125.000 | 125.000 | |
Gary J Herick
10% Owner -
|
202.000 | 202.000 | |
Elie M Khalife Director - [D] | 100.000 | 100.000 | |
Robert M Liess Director - [D] | 1.600.000 | 1.600.000 | |
Matthew Nicosia | 26.000 | ||
Richard Dale Orman | 0 | ||
David R Pohl Director - [D] | 600.000 | 600.000 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Steven J Rule | 50.000 | ||
James F Samuelson | 31.000.000 | ||
Schnittker Christopher P. | 0 | ||
Mathew D Sherwood Director - [D] | 2.330.000 | 2.330.000 | |
James E Smeeding Director - [D] | 2.500.000 | 2.500.000 | |
Andrew Clifford Steedman Chief Operating Officer - [O] | 8.000 | 8.000 | |
Amir David Tal - | 23.368.212 | 23.368.212 | |
Elliot Zemel Director - [D] | 23.368.212 | 23.368.212 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CPMD / CannaPharmaRX, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CPMD / CannaPharmaRX, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-10 | 3 | Tal Amir David | CPMD | Common Stock | D | 23.368.212 | ||||||||
2025-04-10 | 3 | Zemel Elliot Koze Investments LLC is a company that may be deemed to be owned by Elliot Zemel | CPMD | Common shares | I | 23.368.212 | ||||||||
2020-06-26 | 2018-04-20 | 4 | SAMUELSON JAMES F | CPMD | Convertible Preferred Stock | D | 0,00 | 1,0000 | 10.000 | 10 | 31.000.000 | |||
2020-06-19 | 2019-06-17 | 4 | Nicosia Matthew | CPMD | Series A Preferred | D | 0,00 | 1,0000 | -4.000 | -4 | 16.000 | |||
2020-06-19 | 2018-04-20 | 4 | Nicosia Matthew | CPMD | Series A Preferred | D | 0,00 | 1,0000 | -10.000 | -10 | 26.000 | |||
2020-04-29 | 3/A | Colvin Dominic | CPMD | Common Stock | I | 7.988.963 | ||||||||
2020-04-29 | 3/A | Colvin Dominic | CPMD | Common Stock | I | 7.988.963 | ||||||||
2020-04-29 | 2019-10-08 | 4 | Colvin Dominic | CPMD | Common Stock | I | 0,2500 | -1.000.000 | -250 | 6.988.963 | ||||
2020-02-04 | 3 | Cassels John Hamilton | CPMD | Series A Convertible Preferred Stock | D | 8.000 | ||||||||
2020-02-04 | 3 | Cassels John Hamilton | CPMD | Series A Convertible Preferred Stock | D | 8.000 | ||||||||
2020-02-04 | 3 | Cassels John Hamilton | CPMD | Series A Convertible Preferred Stock | D | 8.000 | ||||||||
2020-02-04 | 3 | Steedman Andrew Clifford | CPMD | Series A Convertible Preferred Stock | D | 8.000 | ||||||||
2020-02-04 | 3 | Steedman Andrew Clifford | CPMD | Series A Convertible Preferred Stock | D | 8.000 | ||||||||
2020-02-04 | 3 | Steedman Andrew Clifford | CPMD | Series A Convertible Preferred Stock | D | 8.000 | ||||||||
2020-02-03 | 2019-04-23 | 4/A | SAMUELSON JAMES F | CPMD | Series A Convertible Preferred Stock | D | 0,00 | 1,0000 | -1.200 | -1 | 14.800 | |||
2020-02-03 | 2019-04-23 | 4/A | SAMUELSON JAMES F | CPMD | Series A Convertible Preferred Stock | D | 0,00 | 1,0000 | -4.000 | -4 | 16.000 | |||
2020-02-03 | 2018-04-23 | 4 | SAMUELSON JAMES F | CPMD | Series A Convertible Preferred Stock | D | 0,00 | 1,0000 | -1.200 | -1 | 14.800 | |||
2020-02-03 | 2018-04-23 | 4 | SAMUELSON JAMES F | CPMD | Series A Convertible Preferred Stock | D | 0,00 | 1,0000 | -4.000 | -4 | 16.000 | |||
2019-06-26 | 3 | Colvin Dominic | CPMD | Common Stock | D | 15.977.926 | ||||||||
2019-06-26 | 3 | Colvin Dominic | CPMD | Common Stock | D | 15.977.926 | ||||||||
2019-06-26 | 3 | Colvin Dominic | CPMD | Common Stock | D | 15.977.926 | ||||||||
2019-04-18 | 2015-12-14 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -35.000 | -35 | 202.000 | ||||
2019-04-18 | 2015-08-11 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -10.000 | -10 | 237.000 | ||||
2019-04-18 | 2015-08-11 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -3.000 | -3 | 247.000 | ||||
2019-04-18 | 2015-05-11 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -25.000 | -25 | 250.000 | ||||
2019-04-18 | 2015-04-14 | 4 | Herick Gary J | CPMD | Common Stock | I | -125.000 | 275.000 | ||||||
2019-04-17 | 2019-01-02 | 4 | Herick Gary J | CPMD | Common Stock | I | 2,0000 | 100.000 | 200 | 600.000 | ||||
2019-04-17 | 2019-01-02 | 4 | Herick Gary J | CPMD | Common Stock | I | 2,0000 | 100.000 | 200 | 600.000 | ||||
2019-04-17 | 2019-01-02 | 4 | Herick Gary J | CPMD | Common Stock | I | 2,0000 | 400.000 | 800 | 400.000 | ||||
2019-04-17 | 2018-06-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,5000 | -40.000 | -20 | 0 | ||||
2019-04-17 | 2018-06-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,5000 | -123.500 | -62 | 40.000 | ||||
2019-04-17 | 2018-06-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,5000 | -50.000 | -25 | 163.500 | ||||
2019-04-17 | 2018-06-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,5000 | -2.000 | -1 | 213.500 | ||||
2019-04-17 | 2018-06-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,5000 | -2.000 | -1 | 213.500 | ||||
2019-04-17 | 2018-06-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,5000 | -3.000 | -2 | 217.500 | ||||
2019-04-17 | 2018-06-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,5000 | -3.000 | -2 | 217.500 | ||||
2019-04-17 | 2018-06-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,5000 | -2.500 | -1 | 223.500 | ||||
2019-04-17 | 2018-04-20 | 4 | Herick Gary J | CPMD | Series A Convertible Preferred Stock | I | 0,00 | 20.000 | 20.000 | |||||
2019-04-17 | 2015-12-15 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -30.000 | -30 | 226.000 | ||||
2019-04-17 | 2015-12-15 | 4 | Herick Gary J | CPMD | Common Stock | I | 0,7500 | -100.000 | -75 | 256.000 | ||||
2019-04-17 | 2015-12-15 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -100.000 | -100 | 356.000 | ||||
2019-04-17 | 2015-08-11 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -15.000 | -15 | 456.000 | ||||
2019-04-17 | 2015-08-11 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -25.000 | -25 | 471.000 | ||||
2019-04-17 | 2015-08-11 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -25.000 | -25 | 471.000 | ||||
2019-04-17 | 2015-08-11 | 4 | Herick Gary J | CPMD | Common Stock | I | -3.000 | 496.000 | ||||||
2019-04-17 | 2015-08-11 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -3.000 | -3 | 499.000 | ||||
2019-04-17 | 2015-08-11 | 4 | Herick Gary J | CPMD | Common Stock | I | -10.000 | 502.000 | ||||||
2019-04-17 | 2015-07-31 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -3.000 | -3 | 537.000 | ||||
2019-04-17 | 2015-07-27 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -10.000 | -10 | 540.000 | ||||
2019-04-17 | 2015-07-10 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -50.000 | -50 | 550.000 | ||||
2019-04-17 | 2015-05-03 | 4 | Herick Gary J | CPMD | Common Stock | I | -10.000 | 600.000 | ||||||
2019-04-17 | 2015-05-03 | 4 | Herick Gary J | CPMD | Common Stock | I | -50.000 | 610.000 | ||||||
2019-04-17 | 2015-05-03 | 4 | Herick Gary J | CPMD | Common Stock | I | -200.000 | 660.000 | ||||||
2019-04-17 | 2015-03-09 | 4 | Herick Gary J | CPMD | Common Stock | I | 1,0000 | -50.000 | -50 | 860.000 | ||||
2019-04-16 | 2015-06-29 | 4/A | Herick Gary J Through spouse who is a manager of Whitemoon Energy. | CPMD | Common Stock | I | 400.000 | 400.000 | ||||||
2019-04-16 | 2015-06-29 | 4/A | Herick Gary J As a manager of Arrowhead Consulting. | CPMD | Common Stock | I | 910.000 | 910.000 | ||||||
2019-04-16 | 2015-06-29 | 4/A | Herick Gary J Through spouse and family members. | CPMD | Common Stock | I | 600.000 | 600.000 | ||||||
2019-04-16 | 2015-06-29 | 4/A | Herick Gary J | CPMD | Common Stock | D | 340.000 | 340.000 | ||||||
2019-04-16 | 2015-06-29 | 4/A | Herick Gary J Through CannaPharmaRX, Inc., a Coloradoo corporation, as an officer and director. | CPMD | Common Stock | I | -10.421.120 | 0 | ||||||
2019-04-16 | 2014-11-01 | 4/A | Herick Gary J | CPMD | Stock Options | D | 1,00 | 750.000 | 750.000 | |||||
2015-07-21 | 3 | SMEEDING JAMES E | CPMD | Common Stock | D | 2.500.000 | ||||||||
2015-07-21 | 3 | SMEEDING JAMES E | CPMD | Common Stock | D | 2.500.000 | ||||||||
2015-07-13 | 3 | LIESS ROBERT M | CPMD | Common Stock | D | 1.600.000 | ||||||||
2015-07-13 | 3 | LIESS ROBERT M | CPMD | Common Stock | D | 1.600.000 | ||||||||
2015-07-13 | 3 | SHERWOOD MATHEW D Through spouse | CPMD | Common Stock | I | 2.330.000 | ||||||||
2015-07-13 | 3 | SHERWOOD MATHEW D | CPMD | Common Stock | D | 3.060.000 | ||||||||
2015-07-13 | 3 | SHERWOOD MATHEW D | CPMD | Common Stock | D | 3.060.000 | ||||||||
2015-07-13 | 3 | SHERWOOD MATHEW D Through spouse | CPMD | Common Stock | I | 2.330.000 | ||||||||
2015-07-13 | 3 | SHERWOOD MATHEW D Through spouse | CPMD | Common Stock | I | 2.330.000 | ||||||||
2015-07-13 | 3 | SHERWOOD MATHEW D Through spouse | CPMD | Common Stock | I | 2.330.000 | ||||||||
2015-07-13 | 2015-06-29 | 4 | CROCKER GERALD EUGENE JR Through spouse and family members | CPMD | Common Stock | I | 60.000 | 60.000 | ||||||
2015-07-13 | 2015-06-29 | 4 | CROCKER GERALD EUGENE JR | CPMD | Common Stock | D | 1.188.000 | 1.188.000 | ||||||
2015-07-13 | 2015-06-29 | 4 | CROCKER GERALD EUGENE JR Through CannaPharmaRX, Inc., a Colorado corporation, as an officer and director | CPMD | Common Stock | I | -10.421.120 | 0 | ||||||
2015-07-13 | 2014-11-01 | 4 | CROCKER GERALD EUGENE JR | CPMD | Stock Options | D | 1,00 | 750.000 | 750.000 | |||||
2015-07-13 | 2015-06-29 | 4 | Herick Gary J Through spouse who is a manager of Whitemoon Energy | CPMD | Common Stock | I | 400.000 | 400.000 | ||||||
2015-07-13 | 2015-06-29 | 4 | Herick Gary J As a manager of Arrowhead Consulting | CPMD | Common Stock | I | 650.000 | 650.000 | ||||||
2015-07-13 | 2015-06-29 | 4 | Herick Gary J Through spouse and family members | CPMD | Common Stock | I | 600.000 | 600.000 | ||||||
2015-07-13 | 2015-06-29 | 4 | Herick Gary J | CPMD | Common Stock | D | 340.000 | 340.000 | ||||||
2015-07-13 | 2015-06-29 | 4 | Herick Gary J Through CannaPharmaRX, Inc., a Colorado corporation as an officer and director | CPMD | Common Stock | I | -10.421.120 | 0 | ||||||
2015-07-13 | 2014-11-01 | 4 | Herick Gary J | CPMD | Stock Options | D | 1,00 | 750.000 | 750.000 | |||||
2015-06-30 | 2015-06-29 | 4 | CannaPharmaRX, Inc. | CPMD | Common Stock | D | -10.421.120 | 0 | ||||||
2015-04-01 | 3 | KHALIFE ELIE M Beneficially as Managing Member of USA Capital Investors, LLC | CPMD | Common Stock | I | 100.000 | ||||||||
2015-04-01 | 3 | KHALIFE ELIE M Beneficially as Managing Member of USA Capital Investors, LLC | CPMD | Common Stock | I | 100.000 | ||||||||
2015-04-01 | 2015-04-01 | 4 | Giaquinto Alexander R | CPMD | Option | D | 2,85 | 50.000 | 50.000 | |||||
2015-04-01 | 2015-04-01 | 4 | RULE STEVEN J | CPMD | Option | D | 2,85 | 50.000 | 50.000 | |||||
2015-04-01 | 2015-04-01 | 4 | KHALIFE ELIE M | CPMD | Option | D | 2,85 | 50.000 | 50.000 | |||||
2015-03-05 | 3 | POHL DAVID R | GDHC | Common Stock | D | 600.000 | ||||||||
2015-03-05 | 3 | POHL DAVID R | GDHC | Common Stock | D | 600.000 | ||||||||
2015-03-05 | 2015-02-27 | 4 | DICICCO WENDY F | GDHC | OPTION | D | 2,60 | 50.000 | 50.000 | |||||
2015-03-05 | 2015-02-27 | 4 | POHL DAVID R | GDHC | Option | D | 2,60 | 50.000 | 50.000 | |||||
2015-02-12 | 2015-02-09 | 4 | SCHNITTKER CHRISTOPHER P. | GDHC | STOCK OPTION | D | 2,50 | 2,5000 | 450.000 | 1.125 | 450.000 | |||
2014-09-12 | 3 | COHEN GARY MICHAEL Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 11.842.240 | ||||||||
2014-09-12 | 3 | COHEN GARY MICHAEL Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 19.421.120 | ||||||||
2014-09-12 | 3 | COHEN GARY MICHAEL Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 19.421.120 | ||||||||
2014-09-12 | 3 | COHEN GARY MICHAEL Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 11.842.240 | ||||||||
2014-09-12 | 3 | CROCKER GERALD EUGENE JR Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 19.421.120 | ||||||||
2014-09-12 | 3 | CROCKER GERALD EUGENE JR Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 11.842.240 | ||||||||
2014-09-12 | 3 | CROCKER GERALD EUGENE JR Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 19.421.120 | ||||||||
2014-09-12 | 3 | CROCKER GERALD EUGENE JR Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 11.842.240 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 11.842.240 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 19.421.120 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 11.842.240 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 19.421.120 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 19.421.120 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 19.421.120 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 11.842.240 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 19.421.120 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 11.842.240 | ||||||||
2014-09-12 | 3 | Herick Gary J | GDHC | Common Stock | D | 11.842.240 | ||||||||
2014-09-12 | 3 | Herick Gary J Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 19.421.120 | ||||||||
2014-09-12 | 3 | Herick Gary J Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 11.842.240 | ||||||||
2014-09-12 | 3 | Herick Gary J Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 19.421.120 | ||||||||
2014-09-12 | 3 | Herick Gary J Through CannaPharmaRX, Inc. as an Officer and Director | GDHC | Common Stock | I | 11.842.240 | ||||||||
2014-05-21 | 3 | CannaPharmaRX, Inc. | GDHC | COMMON STOCK | D | 19.421.120 | ||||||||
2014-05-21 | 3 | CannaPharmaRX, Inc. | GDHC | COMMON STOCK | D | 11.842.240 | ||||||||
2014-05-21 | 3 | CannaPharmaRX, Inc. | GDHC | COMMON STOCK | D | 19.421.120 | ||||||||
2014-05-21 | 3 | CannaPharmaRX, Inc. | GDHC | COMMON STOCK | D | 11.842.240 | ||||||||
2014-05-19 | 2014-05-09 | 4 | Cutler David J | GDHC | Common Stock | D | 0,0379 | -1.421.120 | -54 | 0 | ||||
2014-05-19 | 2014-05-09 | 4 | Cutler David J | GDHC | Common Stock | D | -100.000 | 1.421.120 | ||||||
2014-05-19 | 2008-08-22 | 4 | Cutler David J | GDHC | Common Stock | D | 1,0000 | 26.421 | 26 | 1.521.120 | ||||
2014-05-19 | 2014-05-09 | 4 | Green Redgie T | GDHC | Common Stock | D | 100.000 | 125.000 |